{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:21:01Z","timestamp":1777620061078,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.fct.2007.07.013","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T08:57:35Z","timestamp":1185958655000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells"],"prefix":"10.1016","volume":"46","author":[{"given":"Paul","family":"Whittaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane J.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.C.","family":"San","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Betz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold E.","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lowri S.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia C.","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2007.07.013_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jep.2004.04.009","article-title":"Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.)","volume":"93","author":"Anke","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.fct.2007.07.013_bib2","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0024-3205(02)01555-2","article-title":"Kava kava and anxiety: growing knowledge about the efficacy and safety","volume":"70","author":"Bilia","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2007.07.013_bib3","unstructured":"Centers for Disease Control, 2002. Hepatic toxicity possibly associated with kava-containing products -- United States, Germany, and Switzerland, 1999\u20132002. Morb. Mortal. Weekly Rep. 51(47), 1065\u20131067."},{"key":"10.1016\/j.fct.2007.07.013_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1161(75)90059-X","article-title":"Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells","volume":"31","author":"Clive","year":"1975","journal-title":"Mutat. Res."},{"key":"10.1016\/j.fct.2007.07.013_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0027-5107(79)90195-7","article-title":"Validation and characterization of the L5178Y\/TK+\/\u2212 mouse lymphoma mutagen assay system","volume":"59","author":"Clive","year":"1979","journal-title":"Mutat. Res."},{"key":"10.1016\/j.fct.2007.07.013_bib6","doi-asserted-by":"crossref","unstructured":"Clive, D., Bolcsfoldi, G., Clements, J., Cole, J., Homn, M., Majeska, J., Moore, M., Muller, L., Myhr, B., Oberly, T., Oudelhkim, M., Rudd, C., Shimada, H., Sofuni, T., Thybaud, V., Wilcox, P., 1995. Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen. 25, 165\u2013168.","DOI":"10.1002\/em.2850250211"},{"key":"10.1016\/j.fct.2007.07.013_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2003.07.005","article-title":"Kava kava: examining new reports of toxicity","volume":"150","author":"Clouatre","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2007.07.013_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1081\/CLT-120025347","article-title":"Liver function test abnormalities in users of aqueous kava extracts","volume":"41","author":"Clough","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.fct.2007.07.013_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbrc.2004.07.093","article-title":"Composition and biological activity of traditional and commercial kava extracts","volume":"322","author":"Cote","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fct.2007.07.013_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/02652030400010454","article-title":"LC\u2013UV and LC\u2013MS analysis of food and drink products containing kava","volume":"21","author":"de Jager","year":"2004","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.fct.2007.07.013_bib11","unstructured":"Dentali, S.J., 1997. Herb Safety Review. Piper methysticum Forster f. (Piperaceae). Herb Research Foundation, Boulder, CO."},{"key":"10.1016\/j.fct.2007.07.013_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0031-9422(03)00111-0","article-title":"Piperidine alkaloids from Piper methysticum","volume":"63","author":"Dragull","year":"2003","journal-title":"Phytochemistry"},{"key":"10.1016\/j.fct.2007.07.013_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0009-2797(01)00159-4","volume":"134","author":"Easterbrook","year":"2001","journal-title":"Chemico-Biol. Interact."},{"key":"10.1016\/j.fct.2007.07.013_bib14","unstructured":"Food and Drug Administration, 2002. Letter to health-care professionals: FDA issues consumer advisory that kava products may be associated with severe liver injury. US Department of Health and Human Services, Food and Drug Administration. http:\/\/www.cfsan.fda.gov\/\u223cdms\/addskava.html."},{"key":"10.1016\/j.fct.2007.07.013_bib15","series-title":"Principles and Methods of Toxicology","first-page":"777","article-title":"Analysis and characterization of enzymes","author":"Guengerich","year":"1989"},{"key":"10.1016\/j.fct.2007.07.013_bib16","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1021\/jf051853j","article-title":"In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)","volume":"54","author":"Jhoo","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.fct.2007.07.013_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/tx020113r","article-title":"Identification of novel electrophilic metabolites of Piper methysticum Forst. (kava)","volume":"16","author":"Johnson","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2007.07.013_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1124\/dmd.30.11.1153","article-title":"Inhibition of human cytochrome P450 activities by kava extract and kavalactones","volume":"30","author":"Mathews","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2007.07.013_bib19","first-page":"748","article-title":"Inhibition of CYP3A4 in a rapid microtiter plate assay using recombinant enzyme and in human liver microsomes using conventional substrates","volume":"29","author":"Nomeir","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2007.07.013_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-135-1-200107030-00036","article-title":"Kava hepatotoxicity","volume":"135","author":"Russmann","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.fct.2007.07.013_bib21","series-title":"Statistical Methods","author":"Snedecor","year":"1980"},{"key":"10.1016\/j.fct.2007.07.013_bib22","first-page":"420","article-title":"The correlation between cancer incidence and kava consumption","volume":"59","author":"Steiner","year":"2000","journal-title":"Hawaii Med. J."},{"key":"10.1016\/j.fct.2007.07.013_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002018-200225040-00003","article-title":"A systematic review of the safety of kava extract in the treatment of anxiety","volume":"25","author":"Stevinson","year":"2002","journal-title":"Drug Safety"},{"key":"10.1016\/j.fct.2007.07.013_bib24","first-page":"1335","article-title":"Leberschadigungen unter kava-extrakten","volume":"31","author":"Stoller","year":"2000","journal-title":"Schweizerische Arztezeitung"},{"key":"10.1016\/j.fct.2007.07.013_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-9422(03)00381-9","article-title":"Kava lactones and the kava kava controversy","volume":"64","author":"Whitton","year":"2003","journal-title":"Phytochemistry"},{"key":"10.1016\/j.fct.2007.07.013_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/jf010963x","article-title":"Novel compounds from Piper methysticum Forst. (kava kava) roots and their effect on cyclooxygenase enzyme","volume":"50","author":"Wu","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.fct.2007.07.013_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0024-3205(02)01913-6","article-title":"Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity","volume":"71","author":"Zou","year":"2002","journal-title":"Life Sci."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691507002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691507002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:41:07Z","timestamp":1759524067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691507002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0278691507002608"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2007.07.013","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2007.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}